AVONEX - 59627-003-04 - (interferon beta-1a)

Alphabetical Index


Drug Information of AVONEX

Product NDC: 59627-003
Proprietary Name: AVONEX
Non Proprietary Name: interferon beta-1a
Active Ingredient(s): 30    ug/.5mL & nbsp;   interferon beta-1a
Administration Route(s): INTRAMUSCULAR
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of AVONEX

Product NDC: 59627-003
Labeler Name: Biogen Idec MA Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103628
Marketing Category: BLA
Start Marketing Date: 20030523

Package Information of AVONEX

Package NDC: 59627-003-04
Package Description: 4 BOX in 1 CARTON (59627-003-04) > 1 SYRINGE in 1 BOX (59627-003-01) > .5 mL in 1 SYRINGE

NDC Information of AVONEX

NDC Code 59627-003-04
Proprietary Name AVONEX
Package Description 4 BOX in 1 CARTON (59627-003-04) > 1 SYRINGE in 1 BOX (59627-003-01) > .5 mL in 1 SYRINGE
Product NDC 59627-003
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name interferon beta-1a
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAMUSCULAR
Start Marketing Date 20030523
Marketing Category Name BLA
Labeler Name Biogen Idec MA Inc.
Substance Name INTERFERON BETA-1A
Strength Number 30
Strength Unit ug/.5mL
Pharmaceutical Classes Interferon-beta [Chemical/Ingredient],Recombinant Human Interferon beta [EPC],Recombinant Proteins [Chemical/Ingredient]

Complete Information of AVONEX


General Information